National Community Pharmacists Association Statement On "Sense Of Congress" Resolution Opposing FDA Restrictions On Estriol Usage
Main Category: MenopauseAlso Included In: Regulatory Affairs / Drug Approvals; Endocrinology
Article Date: 08 May 2008 - 2:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Yesterday H. Con. Res. 342 was introduced by Rep. Mike Ross (D-Ark.) and Jo Ann Emerson (R-Mo.) opposing the Food and Drug Administration's (FDA) decision to restrict Estriol (a form of Estrogen), a compounded hormone preparation used by women to alleviate the symptoms of menopause. The action was taken after the FDA sent letters to seven pharmacies in January asking them to cease and desist with the use of estriol. At this time, there is insufficient evidence substantiating the need for restriction. In response Bruce Roberts, RPh, executive vice president and CEO of the National Community Pharmacists Association (NCPA), issued the following statement:
"Estriol helps women manage the menopause process and has been proven safe and effective. FDA's decision is not predicated on evidence, therefore questioning their interference in the states' jurisdiction over drug compounding. The National Community Pharmacists Association commends Representatives Mike Ross and Jo Ann Emerson for their 'Sense of Congress' resolution urging the FDA to reconsider their restrictions on the use of Estriol."
NOTE: Representatives Tammy Baldwin (D-Wis.), Michael Burgess (R-Texas), John Carter (R-Texas), Sam Farr (D-Calif.), and Gabrielle Giffords (D-Ariz.) were also instrumental in bringing this much needed language to the House floor.
The National Community Pharmacists Association, founded in 1898, represents the nation's community pharmacists, including the owners of more than 23,000 pharmacies. The nation's independent pharmacies, independent pharmacy franchises, and independent chains dispense nearly half of the nation's retail prescription medicines.
National Community Pharmacists Association
Visit our menopause section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/106726.php>
APA
http://www.medicalnewstoday.com/releases/106726.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



